Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Assets (2021 - 2025)

Historic Return on Assets for Journey Medical (DERM) over the last 5 years, with Q3 2025 value amounting to 0.1%.

  • Journey Medical's Return on Assets rose 1800.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 0.19% for FY2024, which is 1400.0% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Return on Assets is 0.1%, which was up 1800.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Return on Assets ranged from a high of 0.01% in Q2 2024 and a low of 0.47% during Q2 2023
  • In the last 5 years, Journey Medical's Return on Assets had a median value of 0.24% in 2024 and averaged 0.24%.
  • Over the last 5 years, Journey Medical's Return on Assets had its largest YoY gain of 4900bps in 2024, and its largest YoY loss of -1500bps in 2024.
  • Quarter analysis of 5 years shows Journey Medical's Return on Assets stood at 0.47% in 2021, then skyrocketed by 41bps to 0.28% in 2022, then soared by 81bps to 0.05% in 2023, then plummeted by -275bps to 0.2% in 2024, then skyrocketed by 49bps to 0.1% in 2025.
  • Its Return on Assets stands at 0.1% for Q3 2025, versus 0.1% for Q2 2025 and 0.1% for Q1 2025.